rs6473

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 1P and 12B. PP2BP4_StrongBP6_Very_Strong

The NM_000500.9(CYP21A2):​c.1481G>A​(p.Ser494Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S494S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0057 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0030 ( 261 hom. )
Failed GnomAD Quality Control

Consequence

CYP21A2
NM_000500.9 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.227

Publications

9 publications found
Variant links:
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Illumina, PanelApp Australia, Orphanet
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 52 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Trascript score misZ: 1.8021 (below the threshold of 3.09). GenCC associations: The gene is linked to classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form.
BP4
Computational evidence support a benign effect (MetaRNN=0.006213218).
BP6
Variant 6-32041127-G-A is Benign according to our data. Variant chr6-32041127-G-A is described in ClinVar as [Benign]. Clinvar id is 193596.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP21A2NM_000500.9 linkc.1481G>A p.Ser494Asn missense_variant Exon 10 of 10 ENST00000644719.2 NP_000491.4 P08686Q16874Q08AG9
TNXBNM_001365276.2 linkc.*222C>T downstream_gene_variant ENST00000644971.2 NP_001352205.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP21A2ENST00000644719.2 linkc.1481G>A p.Ser494Asn missense_variant Exon 10 of 10 NM_000500.9 ENSP00000496625.1 Q16874
TNXBENST00000644971.2 linkc.*222C>T downstream_gene_variant NM_001365276.2 ENSP00000496448.1 P22105-3

Frequencies

GnomAD3 genomes
AF:
0.00566
AC:
782
AN:
138106
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00188
Gnomad AMI
AF:
0.0291
Gnomad AMR
AF:
0.00497
Gnomad ASJ
AF:
0.00716
Gnomad EAS
AF:
0.00167
Gnomad SAS
AF:
0.0187
Gnomad FIN
AF:
0.00771
Gnomad MID
AF:
0.0109
Gnomad NFE
AF:
0.00697
Gnomad OTH
AF:
0.00738
GnomAD2 exomes
AF:
0.000375
AC:
89
AN:
237558
AF XY:
0.000339
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000589
Gnomad ASJ exome
AF:
0.000737
Gnomad EAS exome
AF:
0.000169
Gnomad FIN exome
AF:
0.000112
Gnomad NFE exome
AF:
0.000529
Gnomad OTH exome
AF:
0.000516
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00301
AC:
4166
AN:
1383480
Hom.:
261
Cov.:
33
AF XY:
0.00309
AC XY:
2125
AN XY:
687484
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00142
AC:
46
AN:
32398
American (AMR)
AF:
0.00271
AC:
116
AN:
42798
Ashkenazi Jewish (ASJ)
AF:
0.0106
AC:
252
AN:
23780
East Asian (EAS)
AF:
0.000721
AC:
28
AN:
38850
South Asian (SAS)
AF:
0.00565
AC:
449
AN:
79458
European-Finnish (FIN)
AF:
0.00553
AC:
245
AN:
44340
Middle Eastern (MID)
AF:
0.00398
AC:
17
AN:
4266
European-Non Finnish (NFE)
AF:
0.00262
AC:
2780
AN:
1061160
Other (OTH)
AF:
0.00413
AC:
233
AN:
56430
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.257
Heterozygous variant carriers
0
488
976
1464
1952
2440
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00566
AC:
782
AN:
138240
Hom.:
0
Cov.:
33
AF XY:
0.00579
AC XY:
392
AN XY:
67722
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00190
AC:
75
AN:
39450
American (AMR)
AF:
0.00496
AC:
70
AN:
14108
Ashkenazi Jewish (ASJ)
AF:
0.00716
AC:
21
AN:
2934
East Asian (EAS)
AF:
0.00167
AC:
8
AN:
4780
South Asian (SAS)
AF:
0.0182
AC:
74
AN:
4058
European-Finnish (FIN)
AF:
0.00771
AC:
73
AN:
9464
Middle Eastern (MID)
AF:
0.0117
AC:
3
AN:
256
European-Non Finnish (NFE)
AF:
0.00697
AC:
422
AN:
60546
Other (OTH)
AF:
0.00780
AC:
15
AN:
1922
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.263
Heterozygous variant carriers
0
96
192
289
385
481
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00676
Hom.:
8

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jul 06, 2017
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency Benign:1
Jun 01, 2022
Newborn Screening Ontario, Children's Hospital of Eastern Ontario (CHEO)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.46
DANN
Benign
0.60
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.021
N
M_CAP
Benign
0.068
D
MetaRNN
Benign
0.0062
T;T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
-0.23
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.50
N;.;N;.
REVEL
Benign
0.076
Sift
Benign
0.45
T;.;T;.
Sift4G
Benign
1.0
T;.;T;.
Polyphen
0.0030
B;B;.;B
Vest4
0.041
MVP
0.25
MPC
0.0098
ClinPred
0.0087
T
GERP RS
2.6
gMVP
0.46
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6473; hg19: chr6-32008904; COSMIC: COSV64473903; COSMIC: COSV64473903; API